Opinion|Videos|November 16, 2026

Collaborative Care in MDD: Referral Triggers and Practical Takeaways

Collaborative care remains more aspiration than practice in much of the country. The panel closes on how to build the referral relationships that work, and the one change each expert wants next month.

This episode, "Collaborative Care in MDD: Referral Triggers and Practical Takeaways," features the panel examining how the pieces of depression care fit together.

Dr. Alva asks Dr. Oyedeji for best practices in collaborative care, including the concrete triggers that should prompt escalation to psychiatry before a patient disengages.

Dr. Oyedeji calls evidence-based practice the hallmark and collaborative care the model, then concedes the field still operates in silos. In many regions, a psychiatric provider may not exist within a reasonable distance. Her recommendation is that primary care colleagues establish standing relationships and know their resources. In her own practice, she takes the first step, reaching out across her county so primary care knows she is available. Reaching across and shaking hands, she says, relieves pressure on colleagues who are already stretched. She describes what she sees on the receiving end. Patients arrive saying they have tried everything, or having sat on the same dose for years with no movement. She does not intend that as criticism, since primary care is usually first. Her rule holds that when in doubt, refer, and she teaches it to the clinicians she precepts. She adds that many of her patients have no primary care provider at all.

Dr. Alva then closes with a lightning round. Dr. Shirikjian says clinicians must stop switching from one SSRI to another, and should learn one novel mechanism and try it. Dr. DeBattista wants more time spent educating patients on what to expect, framing the first month as a period for managing side effects and making changes. Dr. Oyedeji asks for realistic expectations on both sides, and calls the cracks in the system a public health concern. Dr. Clayton closes plainly. She and the patient are shooting for remission, and she does not accept continuing symptoms or a less full life as an endpoint.

Thank you for watching this Psychiatric Times Peer Exchange series on major depressive disorder. Please subscribe to our eNewsletter for information on upcoming video series.


Related to this article